Gold nanoparticles against respiratory diseases: oncogenic and viral pathogens review.
Raji VKaushik PalTean ZaheerNandakumar KalarikkalSabu ThomasFernando Gomes de SouzaAsiya SiPublished in: Therapeutic delivery (2020)
Nanoscale size-dependent properties give nanomaterials unique specifications that are robust in many applications of human medicine. Gold nanoparticles (AuNPs) have recently gained attention because of their unique optical, physical and electrical properties. AuNPs increase the efficacy of biomedical applications in diagnostic treatments for infectious diseases, by targeting or labeling target cells/bioactive compounds. However, it is imperative to develop the regimens for more accurate diagnostic tools, preventive care and effective therapy. Our critical and comprehensive review presents emerging avenues of molecular diagnostics as well as therapeutics translated into clinical approaches. This manuscript critically reviews the rampant future of AuNPs in the diagnosis and treatment of the most important diseases, such as cancer and viruses of respiratory system.
Keyphrases
- gold nanoparticles
- infectious diseases
- high resolution
- induced apoptosis
- endothelial cells
- healthcare
- reduced graphene oxide
- sars cov
- cell cycle arrest
- papillary thyroid
- physical activity
- palliative care
- mental health
- working memory
- quality improvement
- randomized controlled trial
- systematic review
- squamous cell carcinoma
- gram negative
- single molecule
- health insurance
- chronic pain
- childhood cancer